accountExtract not available.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,207 news
and
1,328 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
News
Recent news on this topic.
had stone tools and the wheel, or the personal computer in the Information Age, the Hybrid Age has biotechnology and...
firm Alkermes (ALKS.O) on Monday, cutting its debt pile by two thirds and making it a pure biotechnology firm.
firm Alkermes (ALKS.O) on Monday, cutting its debt pile by two thirds and making it a pure biotechnology firm. Elan...
Shares in Swedish biotech Diamyd Medical (DIAMb.ST In a phase 3 study, antigen-based Diamyd for the treatment of type 1...
had stone tools and the wheel, or the personal computer in the Information Age, the Hybrid Age has biotechnology and...
the target's shareholders spurned last year. Shares of Hertz slipped 17 cents, or 1%, to 16.68. Biotechnology company...
schizophrenia and pain. Elan said the spinoff of EDT?a long-standing aim?will allow it to become a pure neurology-based...
is the drug-delivery arm of Elan Holdings, a biotech based in Dublin. The newly combined company, to be known as...
stock?a substantially bigger offer than one the target's shareholders spurned last year. Shares of Hertz slipped 1%.
Extract not available.
and Drug Administration expects to issue this year "foundational" guidelines for companies seeking to market...
(BUSINESS WIRE) -- Representatives from over 40 small biotech and medical device firms nationwide will convene on...
stock?a substantially bigger offer than one the target's shareholders spurned last year. Shares of Hertz slipped 1%.
MADRID (MarketWatch) -- Biotech group Alkermes Inc. (NASDAQ:ALKS
Extract not available.
Stephen Biggar, global director of equity research at Standard & Poor's. "The drivers are far different for...
substantially bigger offer than one the target's shareholders spurned last year. Shares of Hertz slipped 1.5%.
pause driven by seasonal and other one-off issues. The tech-stuffed Nasdaq is outperforming the S&P 500 today,...
Discussing the merger of drug manufacturers Alkermes and Elan with Richard Pops, Alkermes chairman & CEO.��(CNBC)
than the one the target's shareholders had spurned last year. Shares of Hertz ticked up 0.2%. Biotechnology company...
biochemical startup Verdezyne lands investment from British oil giant BP and Dutch biochemicals company DSM ��� yet...
they don't get used as often as they should. But an innovative new product by a British biotech firm may change men's...
as accessories to its GeneChip microarray instrument system for in vitro diagnostics. Shares of the pharmaceutical,...
a mobile platform continue to be hotly pursued���and Mohr Davidow Ventures has hired Paul Cleveland, an executive with...
Top Sources: Business of Biotechnology
- investorideas.com
- bloomberg.com
- youtube.com
- contrarianprofits.com
- industry.bnet.com
- Forbes.com
- SeekingAlpha.com
- bioedgeconsulting.com
- thestreet.com
- pharma-iq.com
Post a Job
Jobs in this Topic
Account Director - Biotech/Healthcare Communications
Paradigm Staffing
|
San Francisco, CA
Posted: Mar 9
M&A Analyst - Biotech / Pharmaceutical Industry
Top International Biotechnology Firm
|
New York, NY
Posted: Jan 17